Developer docs
API playgroundTry for free, no card

Search company profiles

InterpretOmics

Full company profile

uuid000dzjo

Namestring
InterpretOmics
Legal namestring
Interpretomics
Company typeenum
Private
Founded yearint
2009
Descriptiontext

InterpretOmics is a Bangalore, India-based private biotechnology company founded in 2009 that operates a portfolio of life sciences products centered on next-generation sequencing (NGS) and molecular diagnostics. The company's core platform, iOMICS, is built on Illumina NGS technology and is positioned to serve genomic analysis applications in human health, bio-agriculture, and bio-energy. Surrounding the platform, InterpretOmics offers a catalog of consumable products including ELISA kits for protein detection, the PaxView TB/NTM MPCR-ULFA multiplex PCR kit for tuberculosis differential diagnosis, the ANITIA Canine IgE blood-based allergy test for veterinary use, the HiiScript II U+ one-step qRT-PCR probe kit, and ZENA SARS-CoV-2 and COVID-19 N-Antigen diagnostic kits targeting infectious disease and pandemic testing markets.

Its business model appears to combine direct product sales of branded diagnostic and research reagents with an informational/web presence that publishes scientific blog content linking to third-party laboratory equipment. The website functions in part as a content aggregator covering molecular biology and NGS topics, and the company does not disclose pricing, customer logos, revenue, or distribution partnerships in its public materials. InterpretOmics has raised at least $1.6 million in a 2013 round led by Amarante Shipping, and operates with a headcount of 11-50 employees. There is no disclosed ownership, board, or institutional investor structure beyond that single funding event, and the company is led by founder and CEO Prahalad H. Achutharao.

The company's commercial posture is that of a small, vertically integrated life sciences vendor serving research laboratories, clinical diagnostic labs, biotechnology companies, and (in the veterinary segment) companion-animal practice applications. No named customer references, channel partnerships, M&A activity, regulatory filings, or geographic expansion announcements are present in the input data, and the absence of post-2022 content signals raises questions about the company's current commercial momentum.

Short descriptiontext

InterpretOmics is a Bangalore-based biotechnology company founded in 2009 that offers its iOMICS next-generation sequencing platform alongside ELISA kits, infectious disease PCR diagnostics (TB/NTM, SARS-CoV-2), and veterinary allergy tests for research labs, clinical diagnostics, and biotechnology customers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBangalore, India
HQ citystring
Bangalore
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Keyword5 values
genomics software platforms, molecular diagnostic kits, next generation sequencing, cloud based genomics, biotechnology research tools
Industry3 codes
PRIMARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
SECONDARYHLAHAAAD
Molecular Diagnostics (PCR/NAAT/NGS-based IVD)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics
NAICS code1 code
  • Medical Laboratories621511
SIC code2 codes
  • In Vitro & In Vivo Diagnostic Substances2835
  • Services-Commercial Physical & Biological Research8731
Product category
Genomics & Molecular Diagnostics Software
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

InterpretOmics provides a cloud-based software system (iOMICS) that enables genomics interpretation for human health, bio-agriculture, and bio-energy applications on the Illumina NGS platform. Alongside the software, it sells a portfolio of molecular diagnostic and research kits — including ELISA kits, qRT-PCR probe kits, SARS-CoV-2 N-antigen and direct RT-PCR detection kits, a multiplex TB/NTM PCR kit, and a canine IgE allergy test — to research and clinical laboratory customers.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

InterpretOmics is a biotechnology company offering a portfolio of life sciences products centered around its iOMICS next-generation sequencing platform. The product lineup includes ELISA kits for protein detection, molecular diagnostic products for infectious diseases (COVID-19, TB/NTM), veterinary allergy testing (Canine IgE), and PCR/qPCR reagent kits. The company operates in the precision diagnostics and genomics research space, providing both platform technologies and consumable products for clinical and research applications.

Product and service7 records
1iOMICS NGS/Illumina Platform
CategoryGenomics Software Platform
Description

Next-generation sequencing services and solutions utilizing Illumina platform technology for genomic analysis and research applications, delivered as InterpretOmics' core cloud-based genomics software platform.

2ELISA Kits
CategoryResearch Reagents
Description

Enzyme-linked immunosorbent assay kits for detection and quantification of proteins, antibodies, or antigens in various biological samples, supplied to research and clinical laboratory customers.

3COVID-19 N-Antigen Detection Product
CategoryInfectious Disease Diagnostics
Description

SARS-CoV-2 nucleocapsid protein antigen detection product for COVID-19 diagnosis using chemiluminescent immunoassay technology, intended for clinical diagnostic laboratories.

4PaxView TB/NTM MPCR-ULFA Kit
CategoryInfectious Disease Diagnostics
Description

Multiplex PCR kit for detection and differentiation of Mycobacterium tuberculosis (TB) and non-tuberculous mycobacteria (NTM) infections, for clinical and reference laboratories.

5ANITIA Canine IgE Allergy Test
CategoryVeterinary Diagnostics
Description

Blood-based allergy testing kit for detection of allergen-specific IgE antibodies in dogs, enabling identification of environmental and food allergens for veterinary diagnostic use.

6HiiScript II U+ One Step qRT-PCR Probe Kit
CategoryResearch Reagents
Description

One-step quantitative reverse transcription PCR probe kit with heat-labile UDG anti-contamination system for sensitive detection of RNA targets, used in research and molecular biology workflows.

7ZENA SARS-CoV-2 Direct Detection Kit
CategoryInfectious Disease Diagnostics
Description

Real-time reverse transcriptase PCR (RT-PCR) kit for direct detection of SARS-CoV-2 viral RNA from clinical samples including nasopharyngeal swabs, intended for clinical diagnostic use.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Dominant global NGS platform and instrument provider that also offers bioinformatics software (BaseSpace, DRAGEN) — comparable to InterpretOmics on the iOMICS/Illumina platform positioning, though at vastly larger scale and broader scope.

TypeDirect peer
Description

Bangalore-based genomics informatics and molecular diagnostics company combining bioinformatics software with clinical lab services — directly comparable to InterpretOmics on the dual software-plus-diagnostics model, geographic base, and target customer set in India.

TypeBroad incumbent
Description

Global genomics and molecular diagnostics conglomerate with NGS services, PCR reagents, and COVID-19 testing products — a broad incumbent comparable to InterpretOmics across both the sequencing services and infectious disease diagnostics verticals.

TypeDirect peer
Description

Cloud-based bioinformatics platform for NGS data management and clinical genomics — directly comparable to InterpretOmics's iOMICS cloud software offering, with similar SaaS-based delivery and life sciences customer base.

TypeBroad incumbent
Description

Global molecular diagnostics and sample-preparation technologies company with PCR kits, IVD assays, and bioinformatics (QIAGEN Digital Insights) — overlapping with InterpretOmics's TB/NTM PCR kits, COVID-19 detection, and bioinformatics offerings.

6Xcode Life
TypeEmerging player
Description

India-based personal genomics and bioinformatics company providing DNA-based health and trait reports — a smaller, more consumer-focused peer overlapping with InterpretOmics on genomics interpretation software for the Indian market.

TypeBroad incumbent
Description

Global life sciences tools leader spanning PCR/qPCR instruments and reagents (Applied Biosystems), NGS, and clinical diagnostics — overlapping with InterpretOmics's qRT-PCR reagent kits and broader molecular diagnostics portfolio.

TypeEmerging player
Description

Indian personal genomics and preventive health company offering DNA-based health, wellness, and ancestry tests — overlapping with InterpretOmics on the genomics software/analysis layer and Indian customer base, though more consumer-oriented.

TypeDirect peer
Description

India-headquartered genomics and molecular diagnostics company offering NGS-based genetic testing, hereditary disease diagnostics, and oncology panels. Comparable to InterpretOmics in NGS service delivery and Indian clinical diagnostics focus.

TypeEmerging player
Description

Cloud-based bioinformatics platform supporting multi-omics data analysis and clinical genomics workflows — comparable to InterpretOmics's iOMICS platform in NGS interpretation and tertiary analysis use cases.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

InterpretOmics

Genomics & Molecular Diagnostics Softwareinterpretomics.co

InterpretOmics is a Bangalore-based biotechnology company founded in 2009 that offers its iOMICS next-generation sequencing platform alongside ELISA kits, infectious disease PCR diagnostics (TB/NTM, SARS-CoV-2), and veterinary allergy tests for research labs, clinical diagnostics, and biotechnology customers.

What InterpretOmics does

InterpretOmics is a Bangalore, India-based private biotechnology company founded in 2009 that operates a portfolio of life sciences products centered on next-generation sequencing (NGS) and molecular diagnostics. The company's core platform, iOMICS, is built on Illumina NGS technology and is positioned to serve genomic analysis applications in human health, bio-agriculture, and bio-energy. Surrounding the platform, InterpretOmics offers a catalog of consumable products including ELISA kits for protein detection, the PaxView TB/NTM MPCR-ULFA multiplex PCR kit for tuberculosis differential diagnosis, the ANITIA Canine IgE blood-based allergy test for veterinary use, the HiiScript II U+ one-step qRT-PCR probe kit, and ZENA SARS-CoV-2 and COVID-19 N-Antigen diagnostic kits targeting infectious disease and pandemic testing markets.

Its business model appears to combine direct product sales of branded diagnostic and research reagents with an informational/web presence that publishes scientific blog content linking to third-party laboratory equipment. The website functions in part as a content aggregator covering molecular biology and NGS topics, and the company does not disclose pricing, customer logos, revenue, or distribution partnerships in its public materials. InterpretOmics has raised at least $1.6 million in a 2013 round led by Amarante Shipping, and operates with a headcount of 11-50 employees. There is no disclosed ownership, board, or institutional investor structure beyond that single funding event, and the company is led by founder and CEO Prahalad H. Achutharao.

The company's commercial posture is that of a small, vertically integrated life sciences vendor serving research laboratories, clinical diagnostic labs, biotechnology companies, and (in the veterinary segment) companion-animal practice applications. No named customer references, channel partnerships, M&A activity, regulatory filings, or geographic expansion announcements are present in the input data, and the absence of post-2022 content signals raises questions about the company's current commercial momentum.

InterpretOmics firmographics

Firmographics
Name
InterpretOmics
Legal name
Interpretomics
Website
https://interpretomics.co
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
11–50 employees
Short description
InterpretOmics is a Bangalore-based biotechnology company founded in 2009 that offers its iOMICS next-generation sequencing platform alongside ELISA kits, infectious disease PCR diagnostics (TB/NTM, SARS-CoV-2), and veterinary allergy tests for research labs, clinical diagnostics, and biotechnology customers.
Ownership category
akta.pro rank

InterpretOmics industry classification

Industry
Product category
Genomics & Molecular Diagnostics Software
NAICS
Medical Laboratories (621511)
SIC
In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
SECONDARYHLAHAAAD
Molecular Diagnostics (PCR/NAAT/NGS-based IVD)
Healthcare & Life Sciences/Medical Devices & Diagnostics/In Vitro Diagnostics (IVD) & Laboratory Diagnostics

Keywords

  • Genomics software platforms
  • Molecular diagnostic kits
  • Next generation sequencing
  • Cloud based genomics
  • Biotechnology research tools

Where InterpretOmics is headquartered

Location

Headquarters

HQ city
Bangalore
HQ country
India
HQ region
Asia

Markets served

InterpretOmics business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Marketing channels1 record

InterpretOmics product offering

Product offering

Core offering

InterpretOmics provides a cloud-based software system (iOMICS) that enables genomics interpretation for human health, bio-agriculture, and bio-energy applications on the Illumina NGS platform. Alongside the software, it sells a portfolio of molecular diagnostic and research kits — including ELISA kits, qRT-PCR probe kits, SARS-CoV-2 N-antigen and direct RT-PCR detection kits, a multiplex TB/NTM PCR kit, and a canine IgE allergy test — to research and clinical laboratory customers.

Product overview

InterpretOmics is a biotechnology company offering a portfolio of life sciences products centered around its iOMICS next-generation sequencing platform. The product lineup includes ELISA kits for protein detection, molecular diagnostic products for infectious diseases (COVID-19, TB/NTM), veterinary allergy testing (Canine IgE), and PCR/qPCR reagent kits. The company operates in the precision diagnostics and genomics research space, providing both platform technologies and consumable products for clinical and research applications.

Differentiator

Problem solved

Functional benefit

Products and services

  • iOMICS NGS/Illumina Platform Next-generation sequencing services and solutions utilizing Illumina platform technology for genomic analysis and research applications, delivered as InterpretOmics' core cloud-based genomics software platform.
  • ELISA Kits Enzyme-linked immunosorbent assay kits for detection and quantification of proteins, antibodies, or antigens in various biological samples, supplied to research and clinical laboratory customers.
  • COVID-19 N-Antigen Detection Product SARS-CoV-2 nucleocapsid protein antigen detection product for COVID-19 diagnosis using chemiluminescent immunoassay technology, intended for clinical diagnostic laboratories.
  • PaxView TB/NTM MPCR-ULFA Kit Multiplex PCR kit for detection and differentiation of Mycobacterium tuberculosis (TB) and non-tuberculous mycobacteria (NTM) infections, for clinical and reference laboratories.
  • ANITIA Canine IgE Allergy Test Blood-based allergy testing kit for detection of allergen-specific IgE antibodies in dogs, enabling identification of environmental and food allergens for veterinary diagnostic use.
  • HiiScript II U+ One Step qRT-PCR Probe Kit One-step quantitative reverse transcription PCR probe kit with heat-labile UDG anti-contamination system for sensitive detection of RNA targets, used in research and molecular biology workflows.
  • ZENA SARS-CoV-2 Direct Detection Kit Real-time reverse transcriptase PCR (RT-PCR) kit for direct detection of SARS-CoV-2 viral RNA from clinical samples including nasopharyngeal swabs, intended for clinical diagnostic use.

Companies that use InterpretOmics

Customer profile

Segments1 record

Ideal customer profiles1 record

InterpretOmics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

InterpretOmics partnerships and signals

Strategic signal

Recent moves5 records

Expansion highlights3 records

InterpretOmics competitors and assessment

Company assessment

Broad incumbents

  • Illumina: Dominant global NGS platform and instrument provider that also offers bioinformatics software (BaseSpace, DRAGEN) — comparable to InterpretOmics on the iOMICS/Illumina platform positioning, though at vastly larger scale and broader scope.
  • BGI Group: Global genomics and molecular diagnostics conglomerate with NGS services, PCR reagents, and COVID-19 testing products — a broad incumbent comparable to InterpretOmics across both the sequencing services and infectious disease diagnostics verticals.
  • QIAGEN: Global molecular diagnostics and sample-preparation technologies company with PCR kits, IVD assays, and bioinformatics (QIAGEN Digital Insights) — overlapping with InterpretOmics's TB/NTM PCR kits, COVID-19 detection, and bioinformatics offerings.
  • Thermo Fisher Scientific: Global life sciences tools leader spanning PCR/qPCR instruments and reagents (Applied Biosystems), NGS, and clinical diagnostics — overlapping with InterpretOmics's qRT-PCR reagent kits and broader molecular diagnostics portfolio.

Direct peers

  • Strand Life Sciences: Bangalore-based genomics informatics and molecular diagnostics company combining bioinformatics software with clinical lab services — directly comparable to InterpretOmics on the dual software-plus-diagnostics model, geographic base, and target customer set in India.
  • DNAnexus: Cloud-based bioinformatics platform for NGS data management and clinical genomics — directly comparable to InterpretOmics's iOMICS cloud software offering, with similar SaaS-based delivery and life sciences customer base.
  • MedGenome: India-headquartered genomics and molecular diagnostics company offering NGS-based genetic testing, hereditary disease diagnostics, and oncology panels. Comparable to InterpretOmics in NGS service delivery and Indian clinical diagnostics focus.

Emerging players

  • Xcode Life: India-based personal genomics and bioinformatics company providing DNA-based health and trait reports — a smaller, more consumer-focused peer overlapping with InterpretOmics on genomics interpretation software for the Indian market.
  • Mapmygenome: Indian personal genomics and preventive health company offering DNA-based health, wellness, and ancestry tests — overlapping with InterpretOmics on the genomics software/analysis layer and Indian customer base, though more consumer-oriented.
  • Seven Bridges (now Velsera): Cloud-based bioinformatics platform supporting multi-omics data analysis and clinical genomics workflows — comparable to InterpretOmics's iOMICS platform in NGS interpretation and tertiary analysis use cases.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat2 records

Key risks6 records

Key highlights5 records

Customer concentration

InterpretOmics social profiles

Digital presence

InterpretOmics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

InterpretOmics leadership team

Management profile

Number of profiles

Profiles1 record

InterpretOmics funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

InterpretOmics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about InterpretOmics

What does InterpretOmics do?

InterpretOmics provides a cloud-based software system (iOMICS) that enables genomics interpretation for human health, bio-agriculture, and bio-energy applications on the Illumina NGS platform. Alongside the software, it sells a portfolio of molecular diagnostic and research kits — including ELISA kits, qRT-PCR probe kits, SARS-CoV-2 N-antigen and direct RT-PCR detection kits, a multiplex TB/NTM PCR kit, and a canine IgE allergy test — to research and clinical laboratory customers.

Is InterpretOmics a public or private company?

InterpretOmics is a private company. It is classified as venture growth investor backed and is currently operating.

When was InterpretOmics founded?

InterpretOmics was founded in 2009. It employs 11 to 50 people.

Where is InterpretOmics based?

InterpretOmics is headquartered in Bangalore, India, in the Asia region.

Who are InterpretOmics's main competitors?

Broad incumbents on record are Illumina, BGI Group, QIAGEN and Thermo Fisher Scientific. Direct peers are Strand Life Sciences, DNAnexus and MedGenome. Emerging players are Xcode Life, Mapmygenome and Seven Bridges (now Velsera).

Does InterpretOmics have an API?

No public API is recorded for InterpretOmics.

What industry is InterpretOmics in?

InterpretOmics's product category is Genomics & Molecular Diagnostics Software. Its primary akta.pro industry code is HLAGAJAD, Bioinformatics & Multi-omics Analysis Software, with a secondary code of HLAGADAF, Molecular & Genetic Testing (PCR/NGS/qPCR). Its NAICS code is 621511 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals